Skip to main content
Clinical Trials/ACTRN12621000674831
ACTRN12621000674831RecruitingPhase 4

A multi-centre randomised controlled trial of post-operative doxycycline assessing recovery in patients undergoing endoscopic sinus surgery for the treatment of chronic rhinosinusitis

Dr. Andrew James Wood0 sites50 target enrollmentStarted: June 3, 2021Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
16 Years to o limit (—)
Sex
All

Inclusion Criteria

  • Patient undergoing Bilateral Comprehensive Endoscopic Sinus Surgery for the treatment of chronic rhinosinusitis as defined by the European Position Statement, 2020

Exclusion Criteria

  • Prior sinus surgery
  • Predisposing condition (e.g. Aspirin exacerbated respiratory disease, Granulomatosis with Polyangitis, Cystic fibrosis)
  • Antibiotic usage in the 4 weeks prior to recruitment.

Investigators

Sponsor
Dr. Andrew James Wood

Similar Trials

Doxycycline after sinus surgery | Clinical Trial